Sepracor Shares Plunge on Downgrade

Prudential downgraded Sepracor (SEPR ) to sell from hold. On Monday the company posted a $0.63 Q1 loss vs. a $0.76 loss. Partner Janssen Pharmaceutical suspended trials for ticalopride.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.